Cerebellar Deep Brain Stimulation or VNS for Chronic Post-stroke Motor Rehabilitation
Launched by QILU HOSPITAL OF SHANDONG UNIVERSITY · Mar 4, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called deep brain stimulation to help people who have difficulty using their arms after a stroke. The researchers want to see if stimulating both sides of a part of the brain called the cerebellum is more effective than stimulating just one side. This trial is for people who had their first stroke in a specific area of the brain 12 to 36 months ago and still have moderate to severe weakness in their arm. To participate, individuals need to have some ability to move their arm, but they should not have severe muscle tightness or significant thinking problems.
Participants in this study will receive either bilateral (both sides) or unilateral (one side) stimulation and will be closely monitored to see how it affects their ability to move their arm. The trial is currently recruiting people of all genders between the ages of 18 and 80. This research could help improve rehabilitation strategies for stroke survivors, potentially leading to better outcomes in regaining arm function.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Eligible individuals suffered a first-time, unilateral, ischemic stroke in the middle cerebral artery territory that spared the diencephalon and basal ganglia 12-36 months before surgery.
- • Individuals with persistent moderate-to-severe upper-extremity hemiparesis as defined by an FM-UE score of ≤42
- • Sufficient upper-extremity motor ability to engage in rehabilitation (that is, a score of ≥1 on the FM-UE elbow flexion, elbow extension or finger mass flexion or extension).
- Exclusion Criteria:
- • Excessive spasticity or contracture of the upper-extremity muscles (that is, Modified Ashworth Scale = 4)
- • Severe cognitive impairment (Mini Mental State Examination \< 24)
About Qilu Hospital Of Shandong University
Qilu Hospital of Shandong University is a leading medical institution dedicated to advancing healthcare through innovative clinical research and patient-centered care. Affiliated with Shandong University, the hospital integrates clinical practice with education and research, fostering an environment that promotes scientific discovery and the development of new therapies. With a commitment to high standards of clinical excellence and ethical research practices, Qilu Hospital plays a pivotal role in enhancing patient outcomes and contributing to the global medical community through a diverse range of clinical trials and studies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jinan, Sichuan, China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported